Peter A Thompson Insider Trading $CRVS Corvus Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Peter A Thompson.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Peter A Thompson. Peter A Thompson is Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in ProNAi Therapeutics Inc ($DNAI) and President and CEO in Trubion Pharmaceuticals, Inc ($TRBN) and President, CEO & Treasurer in Trubion Pharmaceuticals, Inc ($TRBN) and Director in Synthorx, Inc. ($THOR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Prevail Therapeutics Inc. ($PRVL) and Director in Edgewise Therapeutics, Inc. ($EWTX).

Peter A Thompson in Corvus Pharmaceuticals, Inc.

Trading Symbol: CRVS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 8,053,298 shares
Current Value: $111,377,111
Latest Transaction: Feb 19 2021
$CRVS Market Capitalization: $293.59M
$CRVS Previous Close: $13.83

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Peter A Thompson in Corvus Pharmaceuticals, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADAP, ALPN, CRVS, DBTX, EWTX, PMVP, PRVL, RPBIF, SRRA, SBTX, THOR, TRBN

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 19 2021	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.50	1,285,714	4,499,999	8,053,298	6.8 M to 8.1 M (+19.00 %)
Jun 12 2020	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	3.27	15,000	49,050	15,000
Mar 23 2020	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	2.00	15,000	30,000	15,000
Aug 08 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.51	142,656	500,723	6,767,584	6.6 M to 6.8 M (+2.15 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.91	59,243	231,640	6,624,928	6.6 M to 6.6 M (+0.90 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.72	565,178	2,102,462	6,565,685	6 M to 6.6 M (+9.42 %)
Jul 01 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	3.34	32,923	109,963	6,000,507	6 M to 6 M (+0.55 %)
Jun 24 2019	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	3.61	15,000	54,150	15,000
Jun 25 2018	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	12.50	15,000	187,500	15,000
Mar 14 2018	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	8.50	588,235	4,999,998	5,967,584	5.4 M to 6 M (+10.94 %)
Jun 09 2017	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	9.70	15,000	145,500	15,000
Jun 27 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.99	900	11,691	5,379,349	5.4 M to 5.4 M (+0.02 %)
Jun 27 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.92	100	1,292	5,378,449	5.4 M to 5.4 M (0.00 %)
Jun 21 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.87	26,083	335,688	5,378,349	5.4 M to 5.4 M (+0.49 %)
Jun 21 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.48	12,300	153,504	5,352,266	5.3 M to 5.4 M (+0.23 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.04	5,000	60,200	5,339,966	5.3 M to 5.3 M (+0.09 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	11.94	5,000	59,700	5,334,966	5.3 M to 5.3 M (+0.09 %)
Jun 16 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.71	10,000	127,100	5,329,966	5.3 M to 5.3 M (+0.19 %)
Jun 13 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.98	20,000	259,600	5,319,966	5.3 M to 5.3 M (+0.38 %)
Jun 13 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.95	30,000	388,500	5,299,966	5.3 M to 5.3 M (+0.57 %)
May 24 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	13.09	4,716	61,732	5,269,966	5.3 M to 5.3 M (+0.09 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.75	61	778	5,265,250	5.3 M to 5.3 M (0.00 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	12.11	2,539	30,747	5,265,189	5.3 M to 5.3 M (+0.05 %)
May 20 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	11.55	4,200	48,510	5,262,650	5.3 M to 5.3 M (+0.08 %)
Mar 29 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	C	0.00	713,776	0	0
Mar 29 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	C	0.00	3,994,674	0	0
Mar 29 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	P	15.00	550,000	8,250,000	5,258,450	4.7 M to 5.3 M (+11.68 %)
Mar 29 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	C	0.00	713,776	0	4,708,450	4 M to 4.7 M (+17.87 %)
Mar 29 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Buy	C	0.00	3,994,674	0	3,994,674	0 to 4 M
Mar 24 2016	CRVS	Corvus Pharmaceuti ...	Thompson Peter A.	Director	Option Exercise	A	15.00	30,000	450,000	30,000

Page: 1